cAMP signaling regulates histone H3 phosphorylation and mitotic entry through a disruption of G2 progression

Experimental Cell Research

Volumn 314, Issue 15, 2008, Pages 2855-2869

  Rodriguez Collazo, Pedro ^a   Snyder, Sara K ^a   Chiffer, Rebecca C ^a   Bressler, Erin A ^a   Voss, Ty C ^a   Anderson, Eric P ^a   Genieser, Hans Gottfried ^c   Smith, Catharine L ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c BIOLOG Life Science Institute   (Germany)

Author keywords

cAMP signaling; Cell cycle; Cyclin B; Cyclin dependent kinase; Histone phosphorylation; Protein kinase A

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANISOMYCIN; AURORA B KINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; HISTONE H3; NOCODAZOLE;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA DAMAGE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERPHASE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

MAMMALIA;

EID: 50049115247     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.06.022     Document Type: Article

References (82)

1. Richards J.S. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol. Endocrinol. 15 (2001) 209-218
2. Stork P.J., and Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12 (2002) 258-266
3. Houslay M.D., and Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58 (2000) 659-668
4. Tasken K., and Stokka A.J. The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem. Soc. Trans 34 (2006) 476-479
5. Koyama H., Bornfeldt K.E., Fukumoto S., and Nishizawa Y. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation. J. Cell Physiol. 186 (2001) 1-10
6. Lerner A., and Epstein P.M. Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies. Biochem. J 393 (2006) 21-41
7. Iwai-Kanai E., and Hasegawa K. Intracellular signaling pathways for norepinephrine-and endothelin-1-mediated regulation of myocardial cell apoptosis. Mol. Cell Biochem. 259 (2004) 163-168
8. Naderi S., Gutzkow K.B., Christoffersen J., Smeland E.B., and Blomhoff H.K. cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation. Eur. J. Immunol. 30 (2000) 1757-1768
9. Blomhoff H.K., Blomhoff R., Stokke T., deLange D.C., Brevik K., Smeland E.B., Funderud S., and Godal T. cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1. J. Cell Physiol. 137 (1988) 583-587
10. Kato J.Y., Matsuoka M., Polyak K., Massague J., and Sherr C.J. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor, (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79 (1994) 487-496
11. Stambrook P.J., and Velez C. Reversible arrest of Chinese hamster V79 cells in G2 by dibutytyl AMP. Exp. Cell Res. 99 (1976) 57-62
12. L'Allemain G., Lavoie J.N., Rivard N., Baldin V., and Pouyssegur J. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 14 (1997) 1981-1990
13. van Oirschot B.A., Stahl M., Lens S.M., and Medema R.H. Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J. Biol. Chem 276 (2001) 33854-33860
14. Lee T.H., Chuang L.Y., and Hung W.C. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 19 (2000) 3766-3773
15. Naderi S., Wang J.Y., Chen T.T., Gutzkow K.B., and Blomhoff H.K. cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA. Mol. Biol. Cell 16 (2005) 1527-1542
16. Kurokawa K., and Kato J. Cyclic AMP delays G2 progression and prevents efficient accumulation of cyclin B1 proteins in mouse macrophage cells. Cell Struct. Funct. 23 (1998) 357-365
17. Nebreda A.R., and Ferby I. Regulation of the meiotic cell cycle in oocytes. Curr. Opin. Cell Biol. 12 (2000) 666-675
18. Han S.J., Chen R., Paronetto M.P., and Conti M. Wee1B is an oocyte-specific kinase involved in the control of meiotic arrest in the mouse. Curr. Biol 15 (2005) 1670-1676
19. Gurley L.R., D'Anna J.A., Barham S.S., Deaven L.L., and Tobey R.A. Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Eur. J. Biochem. 84 (1978) 1-15
20. Goto H., Tomono Y., Ajiro K., Kosako H., Fujita M., Sakurai M., Okawa K., Iwamatsu A., Okigaki T., Takahashi T., and Inagaki M. Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J. Biol. Chem. 274 (1999) 25543-25549
21. Shoemaker C.B., and Chalkley R. H3-specific nucleohistone kinase of bovine thymus chromatin. Purification, characterization, and specificity for threonine residue 3. J. Biol. Chem. 255 (1980) 11048-11055
22. Preuss U., Landsberg G., and Scheidtmann K.H. Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. Nucleic Acids Res. 31 (2003) 878-885
23. Swedlow J.R., and Hirano T. The making of the mitotic chromosome: modern insights into classical questions. Mol. Cell 11 (2003) 557-569
24. Prigent C., and Dimitrov S. Phosphorylation of serine 10 in histone H3, what for?. J. Cell Sci. 116 (2003) 3677-3685
25. Goto H., Yasui Y., Nigg E.A., and Inagaki M. Aurora-B phosphorylates histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 7 (2002) 11-17
26. Adams R.R., Maiato H., Earnshaw W.C., and Carmena M. Essential roles of Drosophila inner centromere protein, (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J. Cell Biol. 153 (2001) 865-880
27. Dai J., Sultan S., Taylor S.S., and Higgins J.M. The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes Dev. 19 (2005) 472-488
28. Thomson S., Clayton A.L., Hazzalin C.A., Rose S., Barratt M.J., and Mahadevan L.C. The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase. EMBO J 18 (1999) 4779-4793
29. DeManno D.A., Cottom J.E., Kline M.P., Peters C.A., Maizels E.T., and Hunzicker-Dunn M. Follicle-stimulating hormone promotes histone H3 phosphorylation on serine-10. Mol. Endocrinol. 13 (1999) 91-105
30. Salvador L.M., Park Y., Cottom J., Maizels E.T., Jones J.C., Schillace R.V., Carr D.W., Cheung P., Allis C.D., Jameson J.L., and Hunzicker-Dunn M. Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells. J. Biol. Chem. 276 (2001) 40146-40155
31. Cheung P., Tanner K.G., Cheung W.L., Sassone-Corsi P., Denu J.M., and Allis C.D. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5 (2000) 905-915
32. Anest V., Hanson J.L., Cogswell P.C., Steinbrecher K.A., Strahl B.D., and Baldwin A.S. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423 (2003) 659-663
33. Yamamoto Y., Verma U.N., Prajapati S., Kwak Y.T., and Gaynor R.B. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423 (2003) 655-659
34. Pennie W.D., Hager G.L., and Smith C.L. Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cAMP signalling pathway. Mol. Cell. Biol 15 (1995) 2125-2134
35. Smith C.L., Wolford R.G., O'Neill T.B., and Hager G.L. Characterization of transiently-and constitutively-expressed progesterone receptors: evidence for two functional states. Mol. Endocrinol. 14 (2000) 956-971
36. Kitabayashi I., Eckner R., Arany Z., Chiu R., Gachelin G., Livingston D.M., and Yokoyama K.K. Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells. EMBO J 14 (1995) 3496-3509
37. Rodriquez-Collazo P., Snyder S.K., Chiffer R.C., Zlatanova J., Leuba S.H., and Smith C.L. cAMP signaling induces rapid loss of histone H3 phosphorylation in mammary-adenocarcinoma-derived cell lines. Exp. Cell Res. 314 (2008) 1-10
38. Hendzel M.J., Wei Y., Mancini M.A., Van H.A., Ranalli T., Brinkley B.R., Bazett-Jones D.P., and Allis C.D. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106 (1997) 348-360
39. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., and Landau N.R. Human immunodeficiency virus type 1 viral protein R, (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69 (1995) 6705-6711
40. Re F., Braaten D., Franke E.K., and Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69 (1995) 6859-6864
41. Kino T., Gragerov A., Valentin A., Tsopanomihalou M., Ilyina-Gragerova G., Erwin-Cohen R., Chrousos G.P., and Pavlakis G.N. Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest. J. Virol. 79 (2005) 2780-2787
42. O'Connell M.J., Walworth N.C., and Carr A.M. The G2-phase DNA-damage checkpoint. Trends Cell Biol 10 (2000) 296-303
43. Norbury C., Blow J., and Nurse P. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J 10 (1991) 3321-3329
44. Gu Y., Rosenblatt J., and Morgan D.O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 11 (1992) 3995-4005
45. Goldstone S., Pavey S., Forrest A., Sinnamon J., and Gabrielli B. Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene 20 (2001) 921-932
46. Furuno N., den E.N., and Pines J. Human cyclin A is required for mitosis until mid prophase. J. Cell Biol. 147 (1999) 295-306
47. Lukas C., Sorensen C.S., Kramer E., Santoni-Rugiu E., Lindeneg C., Peters J.M., Bartek J., and Lukas J. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 401 (1999) 815-818
48. L. D.B., Oakes V., Beamish H., Giles N., Steven F., Somodevilla-Torres M., Desouza C., and Gabrielli B. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene 27 (2008) 4261-4268
49. Hu B., Mitra J., van den H.S., and Enders G.H. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Mol. Cell Biol. 21 (2001) 2755-2766
50. Mitra J., and Enders G.H. Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene 23 (2004) 3361-3367
51. Gong D., Pomerening J.R., Myers J.W., Gustavsson C., Jones J.T., Hahn A.T., Meyer T., and Ferrell J.E. Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr. Biol 17 (2007) 85-91
52. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M., Housman D.E., and Graybiel A.M. A family of cAMP-binding proteins that directly activate Rap1. Science 282 (1998) 2275-2279
53. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
54. Enserink J.M., Christensen A.E., de Rooij J., van Triest M., Schwede F., Genieser H.G., Doskeland S.O., Blank J.L., and Bos J.L. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat.Cell Biol. 4 (2002) 901-906
55. Christensen A.E., Selheim F., de Rooij J., Dremier S., Schwede F., Dao K.K., Martinez A., Maenhaut C., Bos J.L., Genieser H.G., and Doskeland S.O. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278 (2003) 35394-35402
56. Duckworth B.C., Weaver J.S., and Ruderman J.V. G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 16794-16799
57. Yu B., Wang Y., Liu Y., Liu Y., Li X., Wu D., Zong Z., Zhang J., and Yu D. Protein kinase A regulates cell cycle progression of mouse fertilized eggs by means of MPF. Dev. Dyn. 232 (2005) 98-105
58. Smolenski A., Bachmann C., Reinhard K., Honig-Liedl P., Jarchau T., Hoschuetzky H., and Walter U. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J. Biol. Chem. 273 (1998) 20029-20035
59. Burger M.M., Bombik B.M., Breckenridge B.M., and Sheppard J.R. Growth control and cyclic alterations of cyclic AMP in the cell cycle. Nat. New Biol. 239 (1972) 161-163
60. Grieco D., Porcellini A., Avvedimento E.V., and Gottesman M.E. Requirement for cAMP-PKA pathway activation by M phase-promoting factor in the transition from mitosis to interphase. Science 271 (1996) 1718-1723
61. Lecureuil C., Tesseraud S., Kara E., Martinat N., Sow A., Fontaine I., Gauthier C., Reiter E., Guillou F., and Crepieux P. Follicle-stimulating hormone activates p70 ribosomal protein S6 kinase by protein kinase A-mediated dephosphorylation of Thr 421/Ser 424 in primary Sertoli cells. Mol. Endocrinol. 19 (2005) 1812-1820
62. Boutros R., Dozier C., and Ducommun B. The when and wheres of CDC25 phosphatases. Curr. Opin. Cell Biol. 18 (2006) 185-191
63. Mikhailov A., Shinohara M., and Rieder C.L. The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle 4 (2005) 57-62
64. Liu X., Yan S., Zhou T., Terada Y., and Erikson R.L. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23 (2004) 763-776
65. Mahadevan L.C., Willis A.C., and Barratt M.J. Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors. Cell 65 (1991) 775-783
66. Clayton A.L., Rose S., Barratt M.J., and Mahadevan L.C. Phosphoacetylation of histone H3 on c-fos-and c-jun-associated nucleosomes upon gene activation. EMBO J 19 (2000) 3714-3726
67. Zhao R.Y., and Elder R.T. Viral infections and cell cycle G2/M regulation. Cell Res. 15 (2005) 143-149
68. de Rooij J., Rehmann H., van Triest M., Cool R.H., Wittinghofer A., and Bos J.L. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J. Biol. Chem. 275 (2000) 20829-20836
69. Ferrell Jr. J.E. Xenopus oocyte maturation: new lessons from a good egg. Bioessays 21 (1999) 833-842
70. Feliciello A., Gallo A., Mele E., Porcellini A., Troncone G., Garbi C., Gottesman M.E., and Avvedimento E.V. The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells. J. Biol. Chem. 275 (2000) 303-311
71. Fernandez A., Cavadore J.C., Demaille J., and Lamb N. Implications for cAMP-dependent protein kinase in the maintenance of the interphase state. Prog. Cell Cycle Res. 1 (1995) 241-253
72. Zaccolo M., Magalhaes P., and Pozzan T. Compartmentalisation of cAMP and Ca(2+) signals. Curr. Opin. Cell Biol. 14 (2002) 160-166
73. Zaccolo M., Di B.G., Lissandron V., Mancuso L., Terrin A., and Zamparo I. Restricted diffusion of a freely diffusible second messenger: mechanisms underlying compartmentalized cAMP signalling. Biochem. Soc. Trans. 34 (2006) 495-497
74. Rich T.C., Fagan K.A., Tse T.E., Schaack J., Cooper D.M., and Karpen J.W. A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13049-13054
75. Houslay M.D., and Milligan G. Tailoring cAMP-signalling responses through isoform multiplicity. Trends Biochem.Sci 22 (1997) 217-224
76. Berridge M.J. Calcium microdomains: organization and function. Cell Calcium 40 (2006) 405-412
77. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., and Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998) 5858-5868
78. Burma S., Chen B.P., Murphy M., Kurimasa A., and Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276 (2001) 42462-42467
79. Bartek J., and Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3 (2003) 421-429
80. Lindqvist A., Kallstrom H., Lundgren A., Barsoum E., and Rosenthal C.K. Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J. Cell Biol. 171 (2005) 35-45
81. Ferguson A.M., White L.S., Donovan P.J., and Piwnica-Worms H. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol. Cell Biol. 25 (2005) 2853-2860
82. Kawabe T. G2 checkpoint abrogators as anticancer drugs. Mol. Cancer Ther. 3 (2004) 513-519